Xeno Transplants Corporation
XENO
$0.00
$0.000.00%
OTC PK
| 03/31/2008 | 12/31/2007 | 09/30/2007 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 109.80K | 170.10K | 140.80K | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 109.80K | 170.10K | 140.80K | ||
| Operating Income | -109.80K | -170.10K | -140.80K | ||
| Income Before Tax | -109.80K | -170.10K | -140.80K | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -109.80K | -170.10K | -140.80K | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -109.80K | -170.10K | -140.80K | ||
| EBIT | -109.80K | -170.10K | -140.80K | ||
| EBITDA | -109.60K | -170.00K | -140.80K | ||
| EPS Basic | 0.00 | 0.00 | 0.00 | ||
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | ||
| EPS Diluted | 0.00 | 0.00 | 0.00 | ||
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | ||
| Average Basic Shares Outstanding | 40.36M | 40.36M | 40.33M | ||
| Average Diluted Shares Outstanding | 40.36M | 40.36M | 40.33M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||